Skip to main content
OpenTrials

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,815 public trials 832 recruiting studies
Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Pandemic-adapted Caries Care Multicentre Single-group Interventional Study

NCT04666597

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +14 more
Locations
  • Indiana University Indianapolis, Indiana, United States
  • Tufts University Boston, Massachusetts, United States
  • Universidad de Buenos Aires Buenos Aires, Argentina
  • Universidad Nacional de Córdoba Córdoba, Argentina
View all 21 locations
View Trial Details
Completed

A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions

NCT00144248

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +14 more
Locations
  • Boehringer Ingelheim Investigational Site Bakersfield, California, United States
  • Boehringer Ingelheim Investigational Site San Francisco, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • Albany Medical College, MC 142 Albany, New York, United States
View Trial Details
Completed

3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study

NCT00275444

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • Boehringer Ingelheim Investigational Site Fountain Valley, California, United States
  • Living Hope Clinical Trials, Inc. Long Beach, California, United States
  • Boehringer Ingelheim Investigational Site Los Angeles, California, United States
View all 62 locations
View Trial Details
Completed

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

NCT00056641

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • Boehringer Ingelheim Investigational Site Berkeley, California, United States
  • Boehringer Ingelheim Investigational Site Fountain Valley, California, United States
  • Boehringer Ingelheim Investigational Site Los Angeles, California, United States
View all 109 locations
View Trial Details

Related conditions